First-in-maintenance therapy for localized high-grade osteosarcoma: an open-label phase I/II trial of the anti-PD-L1 antibody ZKAB001.

Yan Zhou,Qingcheng Yang,Yang Dong,Tong Ji, Bing Zhang, Cheng Yang,Shuier Zheng,Lina Tang,Chenliang Zhou,Guowei Qian,Yujing Huang,Wenxi Yu,Hongtao Li,Yonggang Wang,Aina He,Zan Shen,Qiyuan Bao,Yingqi Hua,Hongyu Bai, Jiayi Zhao,Xiaoyi Li,Xiangrong Dai,Jianjun Zhang,Haiyan Hu,Yang Yao

Clinical cancer research : an official journal of the American Association for Cancer Research（2022）

引用 2|浏览19

暂无评分

摘要

Switching to maintenance using ZKAB001 showed an acceptable safety profile and provided preliminary evidence of clinical activity in localized osteosarcoma patients.

查看译文

关键词

antibody,first-in-maintenance,high-grade,open-label

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要